Clinical Trial Update: Prostaglandin E1 in Outpatients With Intermittent Claudication [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prostaglandin E1 in outpatients with intermittent claudication due to stage II peripheral arterial occlusive disease; the study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Prostaglandin E1 (alprostadil)

Snippet

Sponsor: UCB Pharma | Conditions: Stage II Peripheral Arterial Occlusive Disease, Intermittent Claudication Fontaine Stage II PAOD | Phase 3 | Status: COMPLETED | Results posted: 2012-06-29